➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Dow
AstraZeneca
Mallinckrodt
Baxter

Last Updated: July 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MITOSOL

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Mitosol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02369458 ↗ Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Platin, 5-FU, Cetuximab, and Taxane Recruiting Washington University School of Medicine Phase 2 2015-04-01 No agent is known to have efficacy in patients with incurable HNSCC that progressed with prior platin, 5-FU, cetuximab and taxane. Herein lies the unmet need to be addressed by this trial. Based on the preclinical and clinical data presented, the investigators propose that mitomycin C will have anti-tumor activity in these patients.
NCT02805257 ↗ Ahmed Glaucoma Valve Surgery With Mitomycin-C Not yet recruiting Asociación para Evitar la Ceguera en México Phase 2 2016-06-01 This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
NCT02805257 ↗ Ahmed Glaucoma Valve Surgery With Mitomycin-C Not yet recruiting Bascom Palmer Eye Institute Phase 2 2016-06-01 This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
NCT02805257 ↗ Ahmed Glaucoma Valve Surgery With Mitomycin-C Not yet recruiting University of Colorado, Denver Phase 2 2016-06-01 This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
NCT02805257 ↗ Ahmed Glaucoma Valve Surgery With Mitomycin-C Not yet recruiting University of Maryland Phase 2 2016-06-01 This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
NCT02805257 ↗ Ahmed Glaucoma Valve Surgery With Mitomycin-C Not yet recruiting University of North Carolina Phase 2 2016-06-01 This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
NCT02805257 ↗ Ahmed Glaucoma Valve Surgery With Mitomycin-C Not yet recruiting Zhongshan Ophthalmic Center, Sun Yet-san University Phase 2 2016-06-01 This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Mitosol

Condition Name

Condition Name for Mitosol
Intervention Trials
Stage III Bladder Cancer AJCC v8 3
Stage IIIA Bladder Cancer AJCC v8 3
Stage IIA Anal Cancer AJCC v8 2
Anal Canal Cloacogenic Carcinoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Mitosol
Intervention Trials
Carcinoma 5
Carcinoma, Squamous Cell 3
Carcinoma, Transitional Cell 3
Urinary Bladder Neoplasms 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Mitosol

Trials by Country

Trials by Country for Mitosol
Location Trials
United States 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Mitosol
Location Trials
Minnesota 2
Florida 1
Arizona 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Mitosol

Clinical Trial Phase

Clinical Trial Phase for Mitosol
Clinical Trial Phase Trials
Phase 3 1
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Mitosol
Clinical Trial Phase Trials
Not yet recruiting 6
Suspended 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mitosol

Sponsor Name

Sponsor Name for Mitosol
Sponsor Trials
National Cancer Institute (NCI) 6
Mayo Clinic 2
Bascom Palmer Eye Institute 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Mitosol
Sponsor Trials
Other 11
NIH 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Boehringer Ingelheim
Johnson and Johnson
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.